Biotage AB: Unique Parallel Peptide Synthesizer with Automated Microwave Technology Offers “the Best of Both Worlds” for Peptide Chemists

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Biotage (STO:BIOTA), a leading supplier of tools and technology for medicinal and analytical chemistry, today announced the eagerly awaited global launch of the Syro Wave™; their new microwave and parallel peptide synthesizer. The Syro Wave™ is a result of the joint development project announced last year between Biotage and MultiSynTech. It combines the proven performance of the established MultiSynTech robotic synthesizer with Biotage microwave technology.